Using 68Ga-DOTATOC PET to evaluate gastroenteropancreatic neuroendocrine tumors
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
This study is testing if a special type of PET scan can help doctors better diagnose gastroenteropancreatic neuroendocrine tumors in adults.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS San Raffaele Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Milan) |
| Trial ID | NCT06155318 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and aims to incorporate 68Ga-DOTATOC PET/CT scans into their diagnostic work-up. The study will assess the effectiveness of this imaging technique, which targets somatostatin receptors commonly found on these tumors, providing high sensitivity and specificity. Patients over 18 years old with a confirmed diagnosis of GEP-NET will be included, while those with contraindications to MRI will be excluded. The goal is to enhance the diagnostic process for GEP-NETs and improve patient management.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with a histological diagnosis of gastroenteropancreatic neuroendocrine tumors.
Not a fit: Patients under 18 years old or those with contraindications to MRI will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnosis and better management of gastroenteropancreatic neuroendocrine tumors.
How similar studies have performed: Previous studies have shown success with similar imaging approaches in diagnosing neuroendocrine tumors, indicating a promising avenue for this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with either histological diagnosis of GEP-NET at radiologic imaging and referred to 68Ga-DOTATOC PET; * Age \> 18 years old; * Willing to provide a signed informed consent. Exclusion Criteria: * Controindications to MR study (i.e. Pacemaker); * Age\< 18 years old.
Where this trial is running
Milan
- Irccs San Raffaele — Milan, Italy (Recruiting)
Study contacts
- Study coordinator: Arturo Chiti
- Email: chiti.arturo@hsr.it
- Phone: 0226432716
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.